| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |